Released on: October 12, 2007, 3:41 pm

Press Release Author: GTCbio

Industry: Biotech

Press Release Summary: GTCbio announces it's the 5th anniversary of its vaccine
conference held annually in Washington D.C.

Press Release Body: MONROVIA, CA - GTCbio is announcing the 5th anniversary of its
vaccine conference held annual in Washington D.C. Vaccines: All Things Considered on
November 7-9 gathers top industry and government officials to discuss recent
developments on vaccines in production, as well as legal and funding issues.
Presenters from FDA, CDC, NIH, BARDA, DHHS, Novartis, GSK Biologicals, Merck,
Bavarian Nordic, Transgene, Acambis, BIO, IOMAI, and many more will present on
vaccines in major markets, emerging and re-emerging markets, policy updates and new
funding opportunities from public and private sources.

The keynote presentation will be given by Dr. David Kaslow, Vice President of
Infectious Diseases and Vaccines Franchise at Merck & Co. Dr. Kaslow's presentation
entitled "Beyond Conventional Vaccine Development: Challenges and Opportunities"
will cover standards for developing and bringing a vaccine into market using
examples such as Gardasil and RotaTeq as well as the future opportunities for new
vaccines.

This year's anniversary conference features a pre-conference workshop on Vaccine
Manufacturing. The workshop, chaired by Dr. George Robertson of the Biomedical
Advanced Research and Development Authority (BARDA) at the Department of Health and
Human Services, will focus on the technologies and challenges of vaccine manufacture
in today\'s marketplace including quality, safety, policy, and examples from the
industry.

Vaccines: All Things Considered provides a comprehensive, in-depth analysis of the
vaccine market, including efforts of immunization from life threatening diseases
such as HIV, cancer, Multiple Sclerosis, new vaccine targets and methods of
delivery, as well as regulatory and funding initiatives. For more information visit
www.gtcbio.com.


Web Site: http://www.gtcbio.com

Contact Details: ABOUT GTCbio

GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.

GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.

Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com

GTCbio
434 W Foothill Blvd.
Monrovia, CA 91016
Ph: 626)256-6405
Fax: 626) 256-6460